Consciously Transfusion of Blood Products. Systematic Review of Indicative Factors for Blood Components Infusion's Trigger

Revista Brasileira de Anestesiologia

Volumn 62, Issue 3, 2012, Pages 402-410

  Bittencourt, Ricardo ^a   Costa, José ^b   Lobo, José Eduardo de Oliveira ^b   Aguiar, Fábio Costa ^b  

^a Maternity Carmela Dutra   (Brazil)

^b Hospital Naval Marcilio Dias   (Brazil)

Author keywords

Anemia; BloodTransfusion; Cell Hypoxia

Indexed keywords

HEMOGLOBIN; LACTIC ACID; PYRUVIC ACID;

ANEMIA; BLOOD COMPONENT; BLOOD FLOW VELOCITY; BLOOD TRANSFUSION; BLOOD VISCOSITY; BLOOD VOLUME; CARBON DIOXIDE TENSION; COST; CRITICALLY ILL PATIENT; ERYTHROCYTE TRANSFUSION; HEALING IMPAIRMENT; HEMOGLOBIN BLOOD LEVEL; HOSPITALIZATION; HUMAN; HYPERLACTATEMIA; HYPOXEMIA; IMMUNE DEFICIENCY; INTENSIVE CARE; MORTALITY; NONHUMAN; OXYGEN CONSUMPTION; OXYGEN SUPPLY; PATIENT MONITORING; REVIEW; RISK; TISSUE BLOOD FLOW;

BLOOD COMPONENT TRANSFUSION; HUMANS;

EID: 84861697181     PISSN: 00347094     EISSN: 1806907X     Source Type: Journal    
DOI: 10.1016/S0034-7094(12)70140-X     Document Type: Review

References (17)

1. Choy Y.C., Lim W.L., Ng S.H. Audit of Perioperative Blood Transfusion. Med J Malaysia 2007, 62:299-302.
2. Silva E.D., Novo R.B. Uso crítico de sangue e seus derivados. Atual Anestesiol SAESP 1997, 3:88-107.
3. Vincent J.L., Baron J.F., Reinhart K., et al. Anemia and blood transfusion in critically III patients. JAMA 2002, 288:1499-1507.
4. Stulberg B.N., Zadzilka J.D. Blood management issues. Using blood management strategies. J Arthroplast 2007, 22(Suppl4):95-98.
5. Inaba S. Allogenic blood transfusion for surgery. Nihon Geka Gakkai Zasshi 2005, 106(1):13-17.
6. Von Bormann B., Aulich S. Critical hematocrit from the viewpoint of the clinician. Beitrage zur Infusionstherapie. 1992, 30:216-223. [discussion 247-64].
7. Stoelting R.K., Miller R.D. Bases de anestesia 2004, Editora Roca. 4a.
8. Weil M.H., Afifi A.A. Experimental and clinical studies on lactate and pyruvate as indicators of the severity of acute circulatory failure (Shock). Circulation (American Heart Association) 1970, 41:989-1001.
9. Smith I., Kumar P., Molloy S. Base excess and lactate as prognostic indicators for patients admitted to intensive care. Intensive Care Med 2001, 27:74-83.
10. Mekontso-Dessap A., Castelain V., Anguel N., et al. Combination of venoarterial PCO2 difference with arteriovenous O2 content difference to detect anaerobic metabolism in patients. Intensive Care Med 2002, 28:272-277.
11. Hébert P.C., Wells G., Blajchman M.A., et al. Transfusion Requirements in Critical Investigators For the Canadian Critical Care Trials Group - A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. New Eng J Med 1999, 340(6):409-417.
12. Felippe H.S., Sannuti Pais R.G., Cassano A.C., Cozza D., Vargas R.A.A. Monitorização com cateter de Swan-Ganz: aspectos clínicos. Arq Bras Med Naval 1999, 60(01):45-67.
13. Practice guideline for blood component therapy. Anesthesiology 1996, 84:732-747. American Society of Anesthesiologists Task Force on Blood Component Therapy.
14. Knobel E., Akamine N., Junior C.J.F., Silva E. Terapia intensiva - Hemodinâmica 2003, Editora Atheneu, Rio de Janeiro.
15. a.
16. Weiskopf R.B. Efficacy of acute normovolemic hemodilution assessed as a function of fraction of blood volume lost. Anesthesiology 2001, 94:439-446.
17. Diretoria Colegiada da Agência nacional de Vigilância Sanitária. Diretrizes para o uso de plasma fresco congelado - PFC de plasma vírus inativo. Resolução-RDC N° 10, de 23 de Janeiro de 2004 - DOU de 20/02/2004.